These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1390219)

  • 21. Treatment of MDS with special reference to the effects of androgen on ineffective erythropoiesis.
    Mitsutani S
    Nihon Ketsueki Gakkai Zasshi; 1988 Dec; 51(8):1455-60. PubMed ID: 2854695
    [No Abstract]   [Full Text] [Related]  

  • 22. [Low dose all-trans retinoic acid and androgen therapy for patients with myelodysplastic syndrome].
    Guan M; Chen SC; Li RS; Ge CW; Zhu HL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):774-8. PubMed ID: 15631659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of isotretinoin on survival of patients with myelodysplastic syndrome.
    Tricot G
    Lancet; 1987 May; 1(8544):1271-2. PubMed ID: 2884408
    [No Abstract]   [Full Text] [Related]  

  • 24. Clofibric acid: a potential therapeutic agent in AML and MDS.
    Fenton SL; Drayson MT; Hewison M; Vickers E; Brown G; Bunce CM
    Br J Haematol; 1999 May; 105(2):448-51. PubMed ID: 10233420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment for the myelodysplastic syndromes.
    Jacobs A
    Haematologica; 1987; 72(6):477-80. PubMed ID: 3126101
    [No Abstract]   [Full Text] [Related]  

  • 26. A randomized trial of 13-cis retinoic acid with or without cytosine arabinoside in patients with the myelodysplastic syndrome.
    Clark RE; Ismail SA; Jacobs A; Payne H; Smith SA
    Br J Haematol; 1987 May; 66(1):77-83. PubMed ID: 3297129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increase in platelet count in older, poor-risk patients with acute myeloid leukemia or myelodysplastic syndrome treated with valproic acid and all-trans retinoic acid.
    Pilatrino C; Cilloni D; Messa E; Morotti A; Giugliano E; Pautasso M; Familiari U; Cappia S; Pelicci PG; Lo Coco F; Saglio G; Guerrasio A
    Cancer; 2005 Jul; 104(1):101-9. PubMed ID: 15895376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of treatment with 13-cis-retinoic acid and ara-C on the hematopoietic stem cells of patients with myelodysplastic syndromes].
    García Marco J; Miguel Sosa A; García Conde J; Miguel García A; Arbona C; Escrig V; Benet I; Navarro I; Ruiz A; Carbonell F
    Sangre (Barc); 1994 Aug; 39(4):241-4. PubMed ID: 7985051
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modifications of erythropoiesis in myelodysplastic syndromes treated with recombinant erythropoietin as evaluated by soluble transferrin receptor, high fluorescence reticulocytes and hypochromic erythrocytes.
    Musto P; Modoni S; Alicino G; Savino A; Longo A; Bodenizza C; Falcone A; D'Arena G; Scalzulli P; Perla G
    Haematologica; 1994; 79(6):493-9. PubMed ID: 7896207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical pharmacology of all-trans retinoic acid (ATRA)].
    Robak T
    Acta Haematol Pol; 1995; 26(3):269-77. PubMed ID: 8525772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 13-cis-retinoic acid v placebo in myelodysplasia.
    Jacobs A; Clark RE
    Blood; 1988 Oct; 72(4):1439-40. PubMed ID: 3167218
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical application of retinoic acid and vitamin D3 derivatives to the treatment of refractory anemias].
    Yoshida Y
    Nihon Rinsho; 1993 Apr; 51(4):1023-8. PubMed ID: 8387118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapy of myelodysplastic syndromes: advances and perspectives. Innsbruck, Austria, October 7-10, 1990.
    Zwierzina H; Mufti GJ; Schmalzl F
    Leukemia; 1991 Feb; 5(2):166-85. PubMed ID: 1708435
    [No Abstract]   [Full Text] [Related]  

  • 34. 13-cis retinoic acid treatment for myelodysplastic syndromes.
    Picozzi VJ; Swanson GF; Morgan R; Hecht F; Greenberg PL
    J Clin Oncol; 1986 Apr; 4(4):589-95. PubMed ID: 3514807
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of all-trans retinoic acid in pediatric patients with leukemia.
    Takitani K; Tamai H; Morinobu T; Kawamura N; Miyake M; Fujimoto T; Mino M
    Jpn J Cancer Res; 1995 Apr; 86(4):400-5. PubMed ID: 7775262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized Phase III Study of Lenalidomide Versus Placebo in RBC Transfusion-Dependent Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes and Ineligible for or Refractory to Erythropoiesis-Stimulating Agents.
    Santini V; Almeida A; Giagounidis A; Gröpper S; Jonasova A; Vey N; Mufti GJ; Buckstein R; Mittelman M; Platzbecker U; Shpilberg O; Ram R; Del Cañizo C; Gattermann N; Ozawa K; Risueño A; MacBeth KJ; Zhong J; Séguy F; Hoenekopp A; Beach CL; Fenaux P
    J Clin Oncol; 2016 Sep; 34(25):2988-96. PubMed ID: 27354480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of myelodysplastic syndrome by combined traditional Chinese medicine and Western medicine therapy].
    Wang XT; He HT
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1993 Jul; 13(7):410-2, 388. PubMed ID: 8251723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro stimulation of erythropoiesis by stem cell factor alone in myelodysplastic syndrome patients with elevated endogenous erythropoietin serum levels.
    Zwierzina H; Bammer T; Rollinger-Holzinger I; Herold M; Fenaux P; Nüssler V; Hoflehner E; Geissler D
    Clin Cancer Res; 1996 Jun; 2(6):1031-8. PubMed ID: 9816264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro study of erythropoiesis in patients with aplastic anemia and myelodysplastic syndromes: a possible tool for prospective determination of the clinical effectiveness of growth factors.
    Aoki A; Shibata A
    Hematol Pathol; 1992; 6(3):143-53. PubMed ID: 1429342
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defective erythropoiesis in myelodysplastic syndromes.
    Patton WN; Bunce CM; Brown G; Larkin S
    J Clin Pathol; 1991 Nov; 44(11):965. PubMed ID: 1752994
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.